Journal of Innovations in Pharmaceutical and Biological Sciences (JIPBS)
eISSN: 2349-2759 | pISSN: 2395-1095 | Vol. 5, Issue 1, 2018, pp. 81-85

Microbial and physicochemical evaluations of paracetamol in different brands of analgesic syrups sold in Bangladesh

Netish Kumar Kundo1, Chand Sultana1, Mohammad Sayful Islam1, Md. Ashraf Ali1, Marina Khatun2, A. H. M. Mazbah Uddin1, Pijush Kanti Roy3, Rana Ahmed1, Md. Mahabubur Rahaman1, Md. Arafat Rahman1

1Department of Pharmacy; Mawlana Bhashani Science and Technology University, Santosh, Tangail-1902, Bangladesh
2Department of Biochemistry and Molecular Biology; Mawlana Bhashani Science and Technology University, Santosh, Tangail-1902, Bangladesh
3Department of Chemistry; Mawlana Bhashani Science and Technology University, Santosh, Tangail-1902, Bangladesh
DOI: 10.56511/JIPBS.2018.v5.i01.pp81-85 | Published: 2018-01-05 | Article page and PDF

Abstract

Different brand of paracetamol syrups are widely used in Bangladesh, especially for pediatric and aged patients. The therapeutic efficacy of pharmaceutical products depends on both microbial and physicochemical qualities of the products. However, liquid dosage forms especially syrups contain high percentage of sucrose that are more susceptible for microbial growth. This investigation was done to evaluate the microbial and physicochemical qualities of two hundred fifty samples of different brands of paracetamol syrups sold in Bangladesh. These brands were investigated according to the in-vitro compendial requirements, which include organoleptic properties such as color and taste, total viable aerobic count, type of isolated microorganisms, physical properties and content of active ingredients. These tests were performed by standard methods and techniques. The investigated five brands of paracetamol syrups were passed the standards of the USP regarding microbial specifications. The physiochemical qualities such as organoleptic test results had red and pink clear liquid with sweet taste in some analgesic syrups but remaining samples are bitter taste that not suitable for pediatric patients. The pH values were ranged from 4.44-5.88. However, the density fluctuated from 1.149-1.184 g/mL. The paracetamol concentration as an active ingredient in the paracetamol syrup was recorded from 94.1% – 103.5%. These findings explained that the five different brands of paracetamol syrups sold in Bangladesh are comply with Pharmacopeia specifications regarding microbial and physicochemical characteristics but for better patient acceptability especially for pediatric patients the taste of some paracetamol syrups should be improved.

Keywords: Content; Evaluation; Microbiological; Analgesic; Pharmacopoeia

Introduction

st In the earlier of the 21 century, microbial contamination of non-sterile drugs is one of the main problems for product recalls and production slowdowns [1].

The presence of microbial contaminants was not only found to cause physicochemical changes that led to the spoilage of numerous products but was also proved to be a potential health hazard to the consumer. Non-sterile dosage forms are not required to be sterile, as recommended by most pharmacopeias, but are required to pass microbial bioburden tests for the absence of certain specified indicator pathogens (Escherichia coli, Salmonella sp., Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans) to ensure their efficacy and safety [2].

Not only the presence of pathogenic microorganisms but the presence of relatively high number non-pathogenic microorganisms is also objectionable in pharmaceutical products. The presence of the large number of nonpathogenic microorganisms in pharmaceuticals is microorganisms can deteriorate active ingredients and can interfere with the desired activity of the product; and secondly, they can produce some metabolites that may be toxic to the consumer [3, 4].

Some oral pharmaceutical drugs, if stored in a favorable environment, can serve as nutrients source for microorganisms. Humidity and high amount of sugar in the oral- liquid drugs-in particular can support the microbial growth. Oral liquid drug formulations such as aqueous solutions, suspensions, emulsions and syrups used in pediatrics are at a more risk of microbial contamination during use due to sweetening agents, reconstitution methods, unsuitable storage and handling defects. Microbial contaminations may ultimately contribute to secondary bacterial infections in pediatric patients [5, 6].

Microbial infections are not only the result of the physical presence of microorganisms, but also their metabolites/ toxins that become harmful even if they are found in minimal quantities. Some of these toxin-related illnesses include acute gastroenteritis, abdominal discomfort, and The nature of the active ingredients, the quality of the vehicle and the attention and attitude of workers involved in their handling influence the incidence of microflora in non-sterile products [18]. The nutrients availability, presence of microorganisms, and oxygen consider the some factors for extent of microbial contamination in non-sterile products [8].

The microbiological quality of pharmaceutical products mainly depends on the quality of raw materials, manufacture process and environment, hygiene of the personnel involved in the manufacture and the storage conditions [9].

The present study was designed to determine the percentage content of paracetamol, physical properties and the microbial contaminants found in some brands of analgesic syrups marketed in Bangladesh.

Materials and methods

Samples collection

Two hundred and fifty samples of analgesic syrups of five different companies having different manufacturing date were collected from various retail pharmacies in Tangail City, Bangladesh and labeled with the code A, B, C, D, and E.

Physical examinations

The color was assessed in each sample by visual examination, whereas the taste was evaluated by using the appropriate, relevant sense organs. The pH value was measured once by a pH meter instrument (Model: HI991001 Waterproof Portable pH Meter). The density measured by density measuring instrument.

Microbiological examination

Total viable aerobic count

Ten mL of the sample was diluted to bottle contained 90 mL of nutrient broth and mixed well. A quantity of 0.1 mL of the diluted sample was spread on the surface of Casein soya bean digest agar and Sabouraud dextrose agar plates. The casein soya bean digest agar plates were incubated at 35°C for three days while the Sabouraud dextrose agar plates were incubated at 25°C for five days with daily observation. All experiments were done in duplicates and controls set up in each round. Colonies were counted, and the mean number of colony forming units per mL of each syrup was calculated and recorded [19].

Identification of isolated microorganisms

The sample of the syrups was placed on various selective media such as MacConkey agar, Sabouraud dextrose agar, Baird Parker agar and xylose lysine deoxycholate and then incubated. The biochemical tests used were oxidase, catalase, methyl red (MR), Voges‐Proskauer (VP), motility indole ornithine decarboxylase (MIO), triple sugar iron (TSI) citrate utilization, urea and mannitol fermentation. Gram staining and Lactophenol cotton blue stain technique [20, 25-26].

Chemical examinations

Determination of paracetamol (PCM) content Preparation of working standard solution

The standard procedure for preparation of PCM working standard solution for syrup containing 120 mg/5 mL. 120 mg of PCM working standard (Supplier: NIP chemicals, Batch No.: PFM-188-06-13, Retest date: 22-06-16) weight was diluted with 50 mL of 0.1 M sodium hydroxide (NaOH) into a volumetric flask (200 mL) and completed by distilled water (DW) to the volume. One mL of the diluted solution was transferred into a volumetric flask (100 mL) contained 10 mL of 0.1 M (NaOH) and completed with DW to a volume [11].

Preparation of sample solution

Five mL from each paracetamol syrup sample was transferred into a volumetric flask (200 mL) contained 50 mL of 0.1 M (NaOH) and completed with DW to a volume. One mL of the diluted solution was moved into a volumetric flask (100 mL) contained 10 mL of 0.1 M (NaOH) and completed with DW to a volume [11].

Sample assayed by UV/visible spectrophotometer

The absorbance of the prepared PCM solutions (working standard and sample) were measured in a UV/visible spectrophotometer (Model: UV-1800 Shimadzu Spectrophotometer) with bandwidth (1 nm), connected to a computer loaded with software, at a wavelength of 257 nm using a mixture of 10 mL of 0.1 M (NaOH) and 90 mL of DW as a blank. Quartz cell was used to measure absorbance of all the PCM solutions [11].

The analysis of results was made as follow:

Percentage (%) = (Absorbance of sample/absorbance of standard) × (concentration of standard/concentration of test) × 100.

Statistical analysis

The obtained data was subjected to statistical analysis of variance (ANOVA) using IBM SPSS statistics software (version 20.0, 2011). Differences in microbial count, isolated microbial, physical and chemical characters were compared ANOVA test. Values of p<0.01 was considered statistically significant.

Results

Physical Parameters Results

The results of physical parameters include the color, description, taste, pH, and density (g/mL) that obtained

Table 1. Physical parameters of the different brands of the paracetamol syrups.

Table 2.Total viable aerobic count in the tested paracetamol syrup samples.
Table 2.Total viable aerobic count in the tested paracetamol syrup samples.
Table 3. Number (No.) and percentage (%) of bacteria and fungi isolated from tested paracetamol syrup samples.
Table 3. Number (No.) and percentage (%) of bacteria and fungi isolated from tested paracetamol syrup samples.
Table 4. Percentage (%) of PMC Content of paracetamol syrups. Product Code PMC Content (%) Minimum Maximum A 98.3 100.2
Table 4. Percentage (%) of PMC Content of paracetamol syrups. Product Code PMC Content (%) Minimum Maximum A 98.3 100.2

from analyzed paracetamol syrup samples are listed in the

Table 1.
Table 1.

A table 2 shows the total viable aerobic count of microorganisms present in the analyzed paracetamol syrup samples.

Parameters Paracetamol Syrup Brand Code A B C

Color Red Red Pink Description Clear solution Clear solution Clear solution Taste Bitter sweet Sweet Bitter sweet pH 5.26 – 5.32 4.82 – 4.90 5.58 Density (g/mL) 1.112 -1.116 1.110 – 1.113 1.083 **The P value is statistically significant at the 0.01 level.

*The P value is not statistically significant at the 0.01 level.

Chemical Results

Figure-1 & Table-4 shows the PCM in the analyzed analgesic syrups samples. The ANOVA test showed that there was a significant difference in the paracetamol content results when compared between analgesic syrup samples with an individual confidence level of 99%.

P value

- D E Red Pink - Clear solution Clear solution - Sweet Sweet - - 5.64 6.12 – 6.18 4.98 – 5.06 <0.01** - 1.088 1.146 – 1.148 1.107-1.109 <0.01**

Figure 1. The Paracetamol (PCM) content results of analyzed analgesic syrup samples.
Figure 1. The Paracetamol (PCM) content results of analyzed analgesic syrup samples.

Discussion

Results obtained from this investigation have revealed that all the syrups complied with the official requirement for microbiological quality of syrups in the total viable aerobic count levels, according to the USP (2007) specification. This is in agreement with the work of other investigators [11-12].

From the findings made in this study, it could be inferred that very small levels of microbial contamination of the syrups in this investigation were observed. The low levels of microbial contamination in tested syrup samples could be due to the adoption of Current Good Manufacturing Practice (cGMP), effective preservative agents and adequate quality control program [13].

The lower total count of bacterial and fungal recorded in the syrups may be attributed to the sugar content of the syrups that provide high osmotic pressure that is inhibitory to many microorganisms. Moreover, syrups are usually filtered prior to bottling [21]. The USP (2007) recommends that Salmonella sp., Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Candida albicans as indicators of pathogenic microorganism contamination of syrups. All the samples of analyzed analgesic syrups were found to be free from the pathogenic microorganisms and passed the USP (2007) specifications. Similar observation was reported by Shaikh et al. (1988) [22].

Absence of coliform and pathogenic bacteria indicated that fecal contamination of water might not occur. Unhygienic environmental condition and improper handling of raw materials, ingredients, and products might be the cause of contamination [14].

Low water activity values usually inhibit the growth of bacteria such as members of the Enterobacteriaceae family, as well as aerobic and anaerobic spore formers, but allow the growth of certain vegetative microorganisms, such as Staphylococci and Micrococci, especially S. aureus, also the fungi such as A. niger, and A. fumigates which grow below a water activity of 0.86 [15].

The results of the present work showed that the most important isolated bacteria from non-sterile pharmaceutical syrups were B. subtilis, M. fulvum, and S. epidermidis, while the most important fungi were A. niger, A. fumigatus, and P. notatum. Staphylococcus sp. and Bacillus sp. might transmit from soil and hands of handler during the preparation of drugs. Their incidence does not always mean that the consumption of medicines are potentially being hazardous to users as not all the strain of Staphylococcus sp. can necessarily produce enterotoxin and higher infectious dose (105-106 CFU/mL) of Bacillus sp. is required [16].

Bacillus subtilis reported to be the most frequent in syrups and are widely distributed in the soil, dust, air, and water and because they are resistant to environmentally destructive factors. S. epidermidis was the most frequently isolated species from oral and topical medicaments. Micrococcus sp. was also isolated from liquid and solid drugs [27-28]. Some of the fungi isolated include species of Aspergillus, Penicillium and Mucor are possible allergic and toxin producers. Aspergillus sp. causes Aspergillosis while Aspergillusflavus produces aflatoxin that is carcinogenic [17].

The types of microorganisms isolated in this study suggest contamination from air, processing unit, during handling, and packaging materials.

In our study, the observation that the syrups were not cloudy is indicative of the absence of undesirable chemical and physical changes as well as the lack of visible microbial growth in the syrups.

In this study, the results showed that some the analgesic syrup samples appearance were red and pink with sweet taste, and this agreement with Ofonaike et al. (2007) [23], but remaining samples was bitter taste that not palatable for pediatric patient.

Liquid preparations for oral use may contain suitable excipients such as stabilizing, flavoring and sweetening agents and coloring matter, authorized by the competent authority (USP, 2007).

As per USP (2007) specifications the pH values in the analgesic syrup contained paracetamol from 3.8–6.1. From the results of Table 1, the pH value results were within the acceptable range according to USP (2007) standards.

The density results in the paracetamol syrup samples were 1.149–1.184 g/mL. The density of a substance is the ratio of its mass to its volume at 20°C. No pharmacopeia stipulates specification or limit for density value but leaves that to competent authority to authorize the density value.

As per USP (2007) specifications the percentage content of paracetamol in analgesic oral syrup ranges are from 90.0%–110.0% of the labeled amount in paracetamol syrups. Table-4 and Figure-1 indicate that products A, B, C, D & E showed values within the USP (2007) specifications for a product to be passed. This is similar observation was reported by Oluseun et al. (2012) [24].

Conclusion

It can be concluded that the five different brands of paracetamol syrup sold in Bangladesh have passed the official requirement for microbiological quality of syrups. Also, the pH value and paracetamol content showed within the USP (2007) specifications for a product to be passed. The organoleptic test results had red and pink clear liquid with sweet taste in some analgesic syrups but remaining samples are bitter taste that not suitable for pediatric patients. It is therefore suggested that for better patient acceptability the taste of some paracetamol syrups should be improved and Good Manufacturing and Packaging Practice, proper treatment of water and air; personal hygiene improvement of the production personnel and pretreatment of natural raw materials be enforced and maintained.

References

References

  1. Jimenez L: Microbial limits. In: Jimenez L (ed), Microbial contamination control in the pharmaceutical industry. Drugs and the Pharmaceutical Sciences 2004; 142: 15-44. Marcel Dekker Inc.: New York.
  2. El-Housseiny R, Aboulwafa MM, Aboulwafa, Elkhatib W, Hassouna N: Recovery and detection of microbial contaminants in some non-sterile pharmaceutical products. J ClinMicrobiol 2013; 4: 736-742.
  3. Gad GF, Aly RAI, Ashour MSE: Microbial evaluation of some non-sterile pharmaceutical preparations commonly used in the Egyptian market. Trop J Pharm Res 2011; 10: 437-445.
  4. Kabir S, Hossain MD: Microbiological quality assessment of vitamin B syrups and antibiotic susceptibility profile of the isolated Escherichia coli. J Pharm BiolSci 2013; 8: 61-64.
  5. Mugoyela V, Mwambete KD: Microbial contamination of non-sterile pharmaceuticals in the public hospital settings. Ther Clin Risk Manag 2010; 6: 443-448.
  6. Khanom S, Das KK, Banik S, Noor R: Microbiological analysis of liquid oral drugs available in Bangladesh. Intern J Pharm PharmSci 2013; 5: 479-482.
  7. Nester MT, Anderson G, Roberts C, Pearsall N: Microbiology–a human perspective. Genitourinary infections and antimicrobial medications. 3rd edn. 2002, Mac Graw Hill Publisher, Madrid, Spain.
  8. Denyer SP, Baird RM: Guide to microbiological control in pharmaceuticals and medical devices. 2nd edn. 2007, Ellis HorwoodChichester: U.K. pp. 504.
  9. Baird RM: Microbial spoilage, infection risk and contamination control. In: Denyer SP, Hodges NA, Gorman SP, Hugo W, and Russell’s A (eds), Pharmaceutical Microbiology. 17th edn. (2004) Blackwell Scientific Publications: London, U.K, pp. 262-284.
  10. Marta Jozwiak-B Benista and Jerzy Z. Nowak: Paracetamol: mechanism of action, applications and safety concern.ActaPoloniaePharmaceutica ñ Drug Research 2014; 71(1): 11-23.
  11. Sudeshika ST, Panagoda GJ, Tennakoon IK: A preliminary study to evaluate the microbiological quality of paediatric oral liquid drug formulations during consumption. Available online at :www.pdn.ac.lk/ahs/dept_and_unit/Pharmacy/Research/preliminary.pdf 2010; [Consulted April 16, 2014].
  12. El-Housseiny R, Aboulwafa MM, Aboulwafa, Elkhatib W, Hassouna N: Recovery and detection of microbial contaminants in some non-sterile pharmaceutical products. J Clin Microbiol 2013; 4: 736-742.
  13. Ogbulie N, Ibe J, Nguma C: The microbial associates of unexpired and expired pediatric syrups. Nig J Microbiol 2009; 23: 1817-1822.
  14. Khanom S, Das KK, Banik S, Noor R: Microbiological analysis of liquid oral drugs available in Bangladesh. Intern J Pharm Pharm Sci 2013; 5: 479-482.
  15. Bloomfield SF: Control of microbial contamination in non-sterile pharmaceuticals, cosmetics and toiletries. In: Microbial quality assurance in pharmaceuticals, cosmetics, and toiletries. 1st edn. 1988; Chichester, Ellis Horwood Limited and Halsted Press, pp150.
  16. Gad GF, Aly RAI, Ashour MSE: Microbial evaluation of some non-sterile pharmaceutical preparations commonly used in the Egyptian market. Trop J Pharm Res 2011; 10: 437-445.
  17. Prescott LM, Harley JP, Klein DA: Microbiology. 17th edn. 2008; Mc Craw-Hill Publisher: New York.
  18. Parker MS: Microbiological contamination and preservation of pharmaceutical preparations. In: Pharmaceutics: The science of dosage from design. 2nd. Churchill Livingstone: China 2000; 220.
  19. Clontz L: Microbial limit and bioburden tests: Validation approaches and nd global requirements. 2 edn. Taylor and Francis Group, LLC: New York 2009; 1-91, 203-204.
  20. Moubasher AH: Soil fungi of Qatar and other Arab countries. The Scientific and Applied Research Centre. The University of Qatar, Doha, Qatar. 1993.
  21. Tukur MA, Muazu J, Mohammed GT: Microbial analysis of brands of multivitamin syrups marketed in Maiduguri, northeast Nigeria. Adv Appl Sci. Res. 2012; 3:3124-3128.
  22. Shaikh D, Jamshed TA, Shaikh R: Microbial contamination of pharmaceutical preparations. Pak J Pharm Sci. 1988; 1: 61-66.
  23. Ofonaike JO, Entato EO, Okhama AO: A study of the pharmaceutical quality of chloroquine and paracetamol products sold in a major Nigerian market. Afr J Health Sci. 2007; 14: 3-4.
  24. Oluseun PE, Abiodun A, Oyelola T, Babatunde I, Ologundudu T: Paracetamol content in tablets and syrups of some common brands in Nigeria. An Inter J Sci Manag 2012; 1: 1-3.
  25. Leboffe MJ, Pierce BE: A photographic atlas for the microbiology laboratory. Morton Publishing. Englewood, Colorado, United States of America. 4th edn. 2011.
  26. Don J, Noel R, James T, George MG Bergey’s manual of systematic bacteriology. Michigan State University: East Lansing, USA 2nd edn. 2004.
  27. Prescott LM, Harley JP, Klein DA: Microbiology. Mc Craw-Hill Publisher: New York. 17th edn. 2008.
  28. Rosa MC, Mosso A, Garcia L, Plaza C: Resistance to the antimicrobial agents of bacteria isolated from non-sterile pharmaceuticals. J Appl Microbiol 1993; 74: 570-577.